Refine
Document type
- Master's Thesis (3)
Language
- English (3)
Has full text
- No (3)
Is part of the Bibliography
- No (3)
Keywords
- Comparative analysis (1)
- Diabetes segment (1)
- IT service industry (1)
- India (1)
- Interest coverage ratio (1)
- Market attractiveness (1)
- Negative interest rate (1)
- OTC segment (1)
- Pharmaceutical Industry (1)
- Pricing strategy (1)
Course of studies
Zombie companies are widely discussed ever since the ‘lost decade’ in Japan. The prolonged recession was experienced for almost two decades and in great deal attributed to the zombie companies. The Eurozone is currently in recession and is experiencing a growing incidence of zombie companies. If this trend is not stopped but encouraged by the negative interest rates, there is a possibility for a prolonged recession or even secular stagnation. This study aims to examine the reasons for the emergence and existence of zombie companies in the past. It discusses the implications zombie companies had on the aggregate macroeconomic indicators. In discusses how zombie companies should be treated and whether they must inevitably be foreclosed. To determine the severity of the problem, it examines the incidence of zombie companies in selected industries in the Euro periphery countries based on their interest coverage ratio (ICR). The results show that there is no significant incidence in the selected markets. It concludes whether currently, the zombie companies are a real threat to the economy of the Eurozone. Furthermore, it suggests ways how the problem of zombie companies should be prevented and treated.
As prerequisite to final graduation of my master in international business management MBA at Business School, Hochschule Furtwangen University, I conducted this Thesis but also as a practical business case that match with the nature of my master’s focus of international business and could be used in real life.
I put myself as a member of project’s managing team for a pharmaceutical company, this team as a part of strategic decision-making process is responsible about assessing different potential international markets and segments as a part of the company plan to expand their operations, tape and penetrate new markets.
Narrowing down the options to two geographic markets (Germany & Saudi Arabia) and two pharmaceutical segments (Diabetes& OTC), starting this assessment with macro analysis (PESTEL) of Germany and Saudi Arabia followed by micro analysis (Porter’s five forces) of the pharmaceutical industry in the two markets of concern, having more in depth review of the two potential segments in each individual market then head to head attractiveness comparative analysis of the two potential segments in the two potential countries showing the pros and cons for each of the potential available opportunities and finally reach a conclusion to solve this business scenario.
In order to satisfy both scientific research basis and business need I utilized Data from both peer reviewed articles, reports from highly trusted international institutions and organizations for their data accuracy and few theoretical books.
Limitation of this paper: taking in consideration that some relevant data i.e., regarding specific market profitability are not accessible due to either company’s confidential policies or data consolidation for example the financial statements of Bayer, the pharmaceutical company shows consolidated data combining Europe and middle east allowing no possibility(for outsider) to directly compare profitability of each specific country, here in our research Germany and Saudi Arabia, also I tried my best to use the most recent accessible data , but some of the most updated relevant data is out of my reach either due to confidentiality or it is paid data that requires funding resources not available in my case as I am doing this Thesis independently not in partnership with a company, these limitations might to some degree affect the precision of the final conclusion.
Pricing is one of the foundations of any company’s market strategy and the only factor of the marketing mix that deals with revenue generation. The other three viz. product, promotion and place deal with expenditure. Pricing strategies provide varied degrees of flexibility based on organizational capabilities and customer segments. Pricing decisions are fundamental to a firm’s growth and are complex in implementation. Based on the author’s research, value-based pricing provides the best fit for all the important pricing factors like cost structure, profit margin, competition, supply and demand, etc. Despite this, cost-based and competition-based pricing strategies are still being widely used. The IT service industry in India has long focused on the competitive advantages of cheap and abundant manpower but the lack of focus on product development together with the emergence of other low waged countries and the growing nature of technology adaptation in the country have presented significant motivation to these IT firms to invest in research and development aimed at enhancing their product portfolio, which can be best taken advantage of by moving their pricing decisions towards a customer-value centric approach. Basing their prices on the different customer segments and focusing on value generation is the best way forward in the face of increased competition from both domestic and international organizations.